S100A9 drives the chronification of psoriasiform inflammation by inducing IL-23/type 3 immunity (2023)
- Authors:
- Melo, Bruno Marcel Silva de
- Veras, Flávio Protásio
- Zwicky, Pascale
- Lima, Diógenes
- Ingelfinger, Florian
- Martins, Timna Varela
- Prado, Douglas da Silva
- Schärli, Stefanie
- Públio, Gabriel Azevedo
- Hiroki, Carlos Hiroji
- Melo, Paulo Henrique
- Saraiva, André
- Norbiato, Thainá
- Lima, Leonardo
- Ryffel, Bernhard
- Vogl, Thomas
- Roth, Johannes
- Nakaya, Helder Takashi Imoto
- Souza, Cacilda da Silva
- Cunha, Fernando de Queiroz
- Cunha, Thiago Mattar
- Alves Filho, José Carlos Farias
- Melo, Bruno Marcel Silva de
- USP affiliated authors: NAKAYA, HELDER TAKASHI IMOTO - FCF ; SOUZA, CACILDA DA SILVA - FMRP ; CUNHA, FERNANDO DE QUEIROZ - FMRP ; CUNHA, THIAGO MATTAR - FMRP ; ALVES FILHO, JOSÉ CARLOS FARIAS - FMRP ; MELO, BRUNO MARCEL SILVA DE - FMRP ; VERAS, FLÁVIO PROTÁSIO - FMRP ; MARTINS, TIMNA VARELA - FMRP ; PÚBLIO, GABRIEL AZEVEDO - FMRP ; MELO, PAULO HENRIQUE DE - FMRP
- Unidades: FCF; FMRP
- DOI: 10.1016/j.jid.2023.02.026
- Subjects: PSORÍASE; IMUNIDADE
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Journal of Investigative Dermatology
- ISSN: 0022-202X
- Volume/Número/Paginação/Ano: v. 143, n. 9, p. 1678-1688, 2023
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
MELO, Bruno Marcel Silva de et al. S100A9 drives the chronification of psoriasiform inflammation by inducing IL-23/type 3 immunity. Journal of Investigative Dermatology, v. 143, n. 9, p. 1678-1688, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.jid.2023.02.026. Acesso em: 11 fev. 2026. -
APA
Melo, B. M. S. de, Veras, F. P., Zwicky, P., Lima, D., Ingelfinger, F., Martins, T. V., et al. (2023). S100A9 drives the chronification of psoriasiform inflammation by inducing IL-23/type 3 immunity. Journal of Investigative Dermatology, 143( 9), 1678-1688. doi:10.1016/j.jid.2023.02.026 -
NLM
Melo BMS de, Veras FP, Zwicky P, Lima D, Ingelfinger F, Martins TV, Prado D da S, Schärli S, Públio GA, Hiroki CH, Melo PH, Saraiva A, Norbiato T, Lima L, Ryffel B, Vogl T, Roth J, Nakaya HTI, Souza C da S, Cunha F de Q, Cunha TM, Alves Filho JCF. S100A9 drives the chronification of psoriasiform inflammation by inducing IL-23/type 3 immunity [Internet]. Journal of Investigative Dermatology. 2023 ; 143( 9): 1678-1688.[citado 2026 fev. 11 ] Available from: https://doi.org/10.1016/j.jid.2023.02.026 -
Vancouver
Melo BMS de, Veras FP, Zwicky P, Lima D, Ingelfinger F, Martins TV, Prado D da S, Schärli S, Públio GA, Hiroki CH, Melo PH, Saraiva A, Norbiato T, Lima L, Ryffel B, Vogl T, Roth J, Nakaya HTI, Souza C da S, Cunha F de Q, Cunha TM, Alves Filho JCF. S100A9 drives the chronification of psoriasiform inflammation by inducing IL-23/type 3 immunity [Internet]. Journal of Investigative Dermatology. 2023 ; 143( 9): 1678-1688.[citado 2026 fev. 11 ] Available from: https://doi.org/10.1016/j.jid.2023.02.026 - Pyruvate kinase M2 mediates IL-17 signaling in keratinocytes driving psoriatic skin inflammation
- The metabolic function of pyruvate kinase M2 regulates reactive oxygen species production and microbial killing by neutrophils
- MMP-9 mediates cross-talk between neutrophils and endothelial cells in psoriasis
- Pyrrolidine dithiocarbamate inhibits superoxide anion-induced pain and inflammation in the paw skin and spinal cord by targeting NF-kB and oxidative stress
- Toll like receptor 9 deficiency in neutrophil improves sepsis outcome preventing down-regulation of CXCR2
- Splenectomy increases neutrophil migration but does not affect mortality in lethal sepsis
- Targeting IL-33/ST2 signaling: regulation of immune function and analgesia
- Probucol attenuates overt pain-like behavior and carrageenan-induced inflammatory hyperalgesia and leukocyte recruitment by inhibiting NF-кB activation and cytokine production without antioxidant effects
- Targeting nitric oxide as a key modulator of sepsis, arthritis and pain
- Curcumin inhibits superoxide anion-induced pain-like behavior and leukocyte recruitment by increasing Nrf2 expression and reducing NF-kB activation
Informações sobre o DOI: 10.1016/j.jid.2023.02.026 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003144010.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
